Literature DB >> 22796040

Biomimetic in vitro oxidation of lapachol: a model to predict and analyse the in vivo phase I metabolism of bioactive compounds.

Michael Niehues1, Valéria Priscila Barros, Flávio da Silva Emery, Marcelo Dias-Baruffi, Marilda das Dores Assis, Norberto Peporine Lopes.   

Abstract

The bioactive naphtoquinone lapachol was studied in vitro by a biomimetic model with Jacobsen catalyst (manganese(III) salen) and iodosylbenzene as oxidizing agent. Eleven oxidation derivatives were thus identified and two competitive oxidation pathways postulated. Similar to Mn(III) porphyrins, Jacobsen catalyst mainly induced the formation of para-naphtoquinone derivatives of lapachol, but also of two ortho-derivatives. The oxidation products were used to develop a GC-MS (SIM mode) method for the identification of potential phase I metabolites in vivo. Plasma analysis of Wistar rats orally administered with lapachol revealed two metabolites, α-lapachone and dehydro-α-lapachone. Hence, the biomimetic model with a manganese salen complex has evidenced its use as a valuable tool to predict and elucidate the in vivo phase I metabolism of lapachol and possibly also of other bioactive natural compounds.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796040     DOI: 10.1016/j.ejmech.2012.06.042

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Inactivation of β-Lapachone Cytotoxicity by Filamentous Fungi that Mimic the Human Blood Metabolism.

Authors:  Camila Raquel Paludo; Eduardo Afonso da Silva-Junior; Eliane de Oliveira Silva; Ricardo Vessecchi; Norberto Peporine Lopes; Mônica Tallarico Pupo; Flavio da Silva Emery; Natália Dos Santos Gonçalves; Raquel Alves Dos Santos; Niege Araçari Jacometti Cardoso Furtado
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.569

2.  Jacobsen catalyst as a cytochrome P450 biomimetic model for the metabolism of monensin A.

Authors:  Bruno Alves Rocha; Anderson Rodrigo Moraes de Oliveira; Murilo Pazin; Daniel Junqueira Dorta; Andresa Piacezzi Nascimento Rodrigues; Andresa Aparecida Berretta; Ana Paula Ferranti Peti; Luiz Alberto Beraldo de Moraes; Norberto Peporine Lopes; Stanislav Pospíšil; Paul Jonathan Gates; Marilda das Dores Assis
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

3.  Rhodamine B oxidation promoted by P450-bioinspired Jacobsen catalysts/cellulose systems.

Authors:  Lucas Bomfim Bolzon; Anna Karolina Dos Santos Bindeiro; Ana Luiza Marques de Oliveira Souza; Lucas Dimarô Zanatta; Rodrigo de Paula; Bruna Costa Cerqueira; Joicy Santamalvina Dos Santos
Journal:  RSC Adv       Date:  2021-11-02       Impact factor: 3.361

4.  Development of long-circulating lapachol nanoparticles: formation, characterization, pharmacokinetics, distribution and cytotoxicity.

Authors:  Qunying Chen; Lu Bai; Xuelin Zhou; Pingxiang Xu; Xiaorong Li; Huanli Xu; Yuanyuan Zheng; Yuming Zhao; Shousi Lu; Ming Xue
Journal:  RSC Adv       Date:  2020-08-14       Impact factor: 4.036

5.  In vitro metabolism studies of erythraline, the major spiroalkaloid from Erythrina verna.

Authors:  Thais Guaratini; Denise Brentan Silva; Aline Cavalli Bizaro; Lucas Rossi Sartori; Hans-Ulrich Humpf; Norberto Peporine Lopes; Letícia Veras Costa-Lotufo; João Luis Callegari Lopes
Journal:  BMC Complement Altern Med       Date:  2014-02-18       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.